People in the News

Premium

Osmetech has appointed Christopher Gleeson to the post of non-executive chairman, and Jon Faiz Kayyem, who invented the company's eSensor technology while at Clinical Micro Sensors, to be vice chairman. Gleeson previously was president and CEO of Ventana Medical Systems, a position he held until after Ventana was purchased by Roche in 2008. Gleeson also previously was general manager of commercial operations for Chiron Diagnostics and he was senior vice president of Bayer Diagnostics.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

The New York Times reports on a project to develop a tree DNA database to uncover instances of illegal logging.

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.